These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19000492)

  • 1. [Effect of the location of previous atherosclerotic disease on prognosis in diabetic patients. The Barbanza Diabetes Study].
    González-Juanatey JR; Grigorian-Shamagian L; Juiz-Crespo MA; Sánchez-Loureiro M; Rodríguez-Moldes E; Dopico-Pita J; Gutiérrez-Fernández G; Torres-Colomer J; Blanco-Rodríguez R; Otero-Raviña F;
    Rev Esp Cardiol; 2008 Nov; 61(11):1168-77. PubMed ID: 19000492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP Study.
    Otero-Raviña F; Grigorian-Shamagian L; Fransi-Galiana L; Názara-Otero C; Fernández-Villaverde JM; del Alamo-Alonso A; Nieto-Pol E; de Santiago-Boullón M; López-Rodríguez I; Cardona-Vidal JM; Varela-Román A; González-Juanatey JR;
    Int J Cardiol; 2009 Jul; 136(1):56-63. PubMed ID: 18617282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors predictive of cardiovascular disease in patients with type-2 diabetes and hypercholesterolemia. ESODIAH study].
    Pintó X; Corbella E; Figueras R; Biarnés J; Ricart W; Morales C; Falkon L; Masana L;
    Rev Esp Cardiol; 2007 Mar; 60(3):251-8. PubMed ID: 17394870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study.
    Gorter PM; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2007 Dec; 24(12):1352-60. PubMed ID: 18042079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease.
    Feringa HH; van Waning VH; Bax JJ; Elhendy A; Boersma E; Schouten O; Galal W; Vidakovic RV; Tangelder MJ; Poldermans D
    J Am Coll Cardiol; 2006 Mar; 47(6):1182-7. PubMed ID: 16545650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative cardiac risk index predicts long-term mortality and health status.
    Hoeks SE; op Reimer WJ; van Gestel YR; Smolderen KG; Verhagen H; van Domburg RT; van Urk H; Poldermans D
    Am J Med; 2009 Jun; 122(6):559-65. PubMed ID: 19376487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of nocturnal blood pressure reduction in resistant hypertension.
    Muxfeldt ES; Cardoso CR; Salles GF
    Arch Intern Med; 2009 May; 169(9):874-80. PubMed ID: 19433699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex does not influence prognosis in diabetic patients. The Barbanza Diabetes study.
    Vidal-Pérez R; Otero-Raviña F; Grigorian-Shamagian L; Parga-García V; Eirís-Cambre MJ; de Frutos-de Marcos C; Caneda-Villar C; de la Fuente-Mariño R; Ramos-González A; González-Juanatey JR;
    Rev Esp Cardiol; 2010 Feb; 63(2):170-80. PubMed ID: 20109414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features and prognosis of patients with chronic cerebrovascular disease (ICBAR study)].
    Vidal-Pérez R; Otero-Raviña F; Domínguez-López J; Fabeiro-Romero D; Gómez-Vázquez JL; de Blas-Abad P; Juiz-Crespo MA; Pastor-Benavent C; Rodríguez-Moldes E; Castillo J; González-Juanatey JR;
    Rev Neurol; 2011 Oct; 53(8):449-56. PubMed ID: 21960384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
    Ruhl CE; Everhart JE
    Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
    Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis.
    Kaye JA; Li L; Jick SS
    Br J Dermatol; 2008 Sep; 159(4):895-902. PubMed ID: 18616778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of cardiovascular risk profile for in-hospital mortality due to cerebral infarction.
    Arboix A; García-Eroles L; Comes E; Oliveres M; Targa C; Balcells M; Pujadas R; Massons J
    Rev Esp Cardiol; 2008 Oct; 61(10):1020-9. PubMed ID: 18817678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macro and microvascular complications are determinants of increased infection-related mortality in Brazilian type 2 diabetes mellitus patients.
    Cardoso CR; Salles GF
    Diabetes Res Clin Pract; 2007 Jan; 75(1):51-8. PubMed ID: 16713010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry.
    Barba R; Bisbe J; Pedrajas JN; Toril J; Monte R; Muñoz-Torrero JF; Monreal M;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):457-63. PubMed ID: 19369873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.
    Brugts JJ; Ninomiya T; Boersma E; Remme WJ; Bertrand M; Ferrari R; Fox K; MacMahon S; Chalmers J; Simoons ML
    Eur Heart J; 2009 Jun; 30(11):1385-94. PubMed ID: 19346520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.